Two Sigma Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Two Sigma Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,600	Closed	-$1.73M	–	3472
2021 Q4	$1.73M	Sell	13,600 -25,200	-65%	-$3.31M	﹤0.01%	2053
2021 Q3	$5.05M	Buy	+38,800	New	+$5.86M	0.01%	1219
2019 Q4	–	Sell	-2,000	Closed	-$256K	–	3820
2019 Q3	$256K	Hold	2,000	–	–	﹤0.01%	3052
2019 Q2	$285K	Buy	2,000 +300	+18%	+$40.3K	﹤0.01%	2890
2019 Q1	$243K	Buy	+1,700	New	+$222K	﹤0.01%	2728
2018 Q2	–	Sell	-3,200	Closed	-$483K	–	3479
2018 Q1	$483K	Buy	+3,200	New	+$469K	﹤0.01%	2487
2017 Q4	–	Sell	-10,700	Closed	-$1.56M	–	3264
2017 Q3	$1.56M	Buy	+10,700	New	+$1.62M	0.01%	1447
2017 Q1	–	Sell	-13,000	Closed	-$1.42M	–	3101
2016 Q4	$1.42M	Buy	+13,000	New	+$1.45M	0.01%	1753

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Two Sigma Investments's JAZZ Position: Q1 2026 in Review

Two Sigma Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 717% in Q1 2026, buying an estimated $3.01M and bringing the position to 19,600 shares worth $3.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Two Sigma Investments first reported a position in JAZZ in Q2 2013 and has held it in 40 quarters since. The position peaked at $65.2M in Q2 2016. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Two Sigma Investments held 19,600 shares of Jazz Pharmaceuticals worth $3.71M as of Q1 2026.
Two Sigma Investments bought 17,200 Jazz Pharmaceuticals shares in Q1 2026, an estimated $3.01M.
Jazz Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2243 holding.
Two Sigma Investments first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
Two Sigma Investments's Jazz Pharmaceuticals position peaked at $65.2M in Q2 2016.
571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.